These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34913841)

  • 1. Computational investigation of potent inhibitors against YsxC: structure-based pharmacophore modeling, molecular docking, molecular dynamics, and binding free energy.
    Kumari R; Rathi R; Pathak SR; Dalal V
    J Biomol Struct Dyn; 2023 Feb; 41(3):930-941. PubMed ID: 34913841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular dynamics simulation of the Staphylococcus aureus YsxC protein: molecular insights into ribosome assembly and allosteric inhibition of the protein.
    Goyal A; Muthu K; Panneerselvam M; Pole AK; Ramadas K
    J Mol Model; 2011 Dec; 17(12):3129-49. PubMed ID: 21360172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of potential inhibitors for LLM of
    Kumari R; Dalal V
    J Biomol Struct Dyn; 2022; 40(20):9833-9847. PubMed ID: 34096457
    [No Abstract]   [Full Text] [Related]  

  • 4. Promising antibacterials for LLM of
    Rathi R; Kumari R; Pathak SR; Dalal V
    J Biomol Struct Dyn; 2023; 41(15):7277-7289. PubMed ID: 36073371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential inhibitors of FemC to combat
    Rathi R
    J Biomol Struct Dyn; 2023 Dec; 41(20):10495-10506. PubMed ID: 36524526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
    Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
    J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dynamics simulation, 3D-pharmacophore and scaffold hopping analysis in the design of multi-target drugs to inhibit potential targets of COVID-19.
    Fayyazi N; Mostashari-Rad T; Ghasemi JB; Ardakani MM; Kobarfard F
    J Biomol Struct Dyn; 2022; 40(22):11787-11808. PubMed ID: 34405765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between Bacillus subtilis YsxC and ribosomes (or rRNAs).
    Wicker-Planquart C; Jault JM
    FEBS Lett; 2015 Apr; 589(9):1026-32. PubMed ID: 25771857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insight parameter drug design for human β-tryptase inhibition integrated molecular docking, QSAR, molecular dynamics simulation, and pharmacophore modelling studies of α-keto-[1,2,4]-oxadiazoles.
    Yu CX; Tan JW; Rullah K; Imran S; Tham CL
    J Biomol Struct Dyn; 2023; 41(22):12978-12996. PubMed ID: 36709457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple e-Pharmacophore modeling to identify a single molecule that could target both streptomycin and paromomycin binding sites for 30S ribosomal subunit inhibition.
    C P A; Subhramanian S; Sizochenko N; Melge AR; Leszczynski J; Mohan CG
    J Biomol Struct Dyn; 2019 Apr; 37(6):1582-1596. PubMed ID: 29633917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The C-terminal α-helix of YsxC is essential for its binding to 50S ribosome and rRNAs.
    Wicker-Planquart C; Ceres N; Jault JM
    FEBS Lett; 2015 Jul; 589(16):2080-6. PubMed ID: 26103561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual screening and structure-based 3D pharmacophore approach to identify small-molecule inhibitors of SARS-CoV-2 M
    Elseginy SA
    J Biomol Struct Dyn; 2022; 40(24):13658-13674. PubMed ID: 34676801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based pharmacophore modeling, virtual screening and simulation studies for the identification of potent anticancerous phytochemical lead targeting cyclin-dependent kinase 2.
    Sharma M; Sharma N; Muddassir M; Rahman QI; Dwivedi UN; Akhtar S
    J Biomol Struct Dyn; 2022; 40(20):9815-9832. PubMed ID: 34151738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of SARS-CoV-2 RNA dependent RNA polymerase inhibitors using pharmacophore modelling, molecular docking and molecular dynamics simulation approaches.
    Pundir H; Joshi T; Pant M; Bhat S; Pandey J; Chandra S; Tamta S
    J Biomol Struct Dyn; 2022; 40(24):13366-13377. PubMed ID: 34637693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel human nicotinamide N-methyltransferase inhibitors: a structure-based pharmacophore modeling and molecular dynamics approach.
    Harikrishna AS; Venkitasamy K
    J Biomol Struct Dyn; 2023; 41(24):14638-14650. PubMed ID: 36856058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YsxC, an essential protein in Staphylococcus aureus crucial for ribosome assembly/stability.
    Cooper EL; García-Lara J; Foster SJ
    BMC Microbiol; 2009 Dec; 9():266. PubMed ID: 20021644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential inhibitors for FKBP51: an
    Barge S; Jade D; Ayyamperumal S; Manna P; Borah J; Nanjan CMJ; Nanjan MJ; Talukdar NC
    J Biomol Struct Dyn; 2022; 40(24):13799-13811. PubMed ID: 34709133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-based pharmacophore modeling of TNF-α to design novel inhibitors using virtual screening and molecular dynamics.
    Jade DD; Pandey R; Kumar R; Gupta D
    J Biomol Struct Dyn; 2022 Mar; 40(4):1702-1718. PubMed ID: 33034255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homology modeling, docking and structure-based virtual screening for new inhibitor identification of
    Panda SK; Saxena S; Guruprasad L
    J Biomol Struct Dyn; 2020 Apr; 38(7):1887-1902. PubMed ID: 31179839
    [No Abstract]   [Full Text] [Related]  

  • 20. In silico discovery of food-derived phytochemicals against asialoglycoprotein receptor 1 for treatment of hypercholesterolemia: Pharmacophore modeling, molecular docking and molecular dynamics simulation approach.
    Gao S; Wang L; Bai F; Xu S
    J Mol Graph Model; 2023 Dec; 125():108614. PubMed ID: 37651861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.